{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,4,29]],"date-time":"2025-04-29T04:06:42Z","timestamp":1745899602586,"version":"3.40.4"},"reference-count":38,"publisher":"Public Library of Science (PLoS)","issue":"4","license":[{"start":{"date-parts":[[2025,4,28]],"date-time":"2025-04-28T00:00:00Z","timestamp":1745798400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Thailand Science Research and Innovation Fundamental Fund Fiscal Year 2023","award":["2023"],"award-info":[{"award-number":["2023"]}]},{"DOI":"10.13039\/501100005790","name":"Thammasat University","doi-asserted-by":"crossref","award":["2023"],"award-info":[{"award-number":["2023"]}],"id":[{"id":"10.13039\/501100005790","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100004704","name":"National Research Council of Thailand","doi-asserted-by":"crossref","award":["N42A671041"],"award-info":[{"award-number":["N42A671041"]}],"id":[{"id":"10.13039\/501100004704","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS One"],"abstract":"<jats:sec id=\"sec029\">\n<jats:title>Background<\/jats:title>\n<jats:p>The FACT-Hep questionnaire has been used to evaluate the health-related quality of life (HRQOL) in various types of hepatobiliary cancer. Nevertheless, the application in intrahepatic cholangiocarcinoma (iCCA) has been limited. The study aimed to validate the applicability of FACT-Hep as a reliable tool for evaluating HRQOL in patients with advanced-stage iCCA.<\/jats:p>\n<\/jats:sec>\n<jats:sec id=\"sec030\">\n<jats:title>Methods<\/jats:title>\n<jats:p><jats:italic>Atractylodes lancea<\/jats:italic> capsules were tested for efficacy and safety in a randomized, controlled phase IIA. Internal consistency, intraclass correlation, test-retest reliability, discriminant and convergent validity, and FACT-Hep score-clinical response connection were assessed.<\/jats:p>\n<\/jats:sec>\n<jats:sec id=\"sec031\">\n<jats:title>Results<\/jats:title>\n<jats:p>Thirty-nine patients qualified for the research. Cronbach\u2019s alpha coefficients &gt; 0.7 showed internal consistency for all subscale items from baseline (day 1) to 90 days. For ICC, convergent, and discriminant validity, all items except the HepCS subscale were reliable. Patients with ECOG scores of 0\u20131 or 2 had significantly different HepCS subscale values\u2014calculated effect size for subscale score change over time. FACT-G and FWB differed significantly in low-dose group 1. At 3-month, 1-month, and 2-month follow-ups, Group 2 (high dose) patients had significant differences in FACT-Hep, TOI, and HepCS. The effect size was the same in Group 3 (untreated). Group 1 and 2 non-progressive patients exhibited lower FWB and EWB scores than progressive patients. The treated survivors had lower FACT-Hep, TOI, HepCS, FWB, and EWB scores than the non-treated survivors, which was linked to AL treatment side effects.<\/jats:p>\n<\/jats:sec>\n<jats:sec id=\"sec032\">\n<jats:title>Conclusion<\/jats:title>\n<jats:p>The FACT-Hep detects changes and is a reliable and valid tool for assessing HRQOL in patients with advanced-stage iCCA.<\/jats:p>\n<\/jats:sec>","DOI":"10.1371\/journal.pone.0321618","type":"journal-article","created":{"date-parts":[[2025,4,28]],"date-time":"2025-04-28T17:33:47Z","timestamp":1745861627000},"page":"e0321618","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":0,"title":["The first validation of the Functional Assessment of Cancer Therapy Hepatobiliary (FACT-Hep) for evaluating health-related quality of life (HRQOL) in patients with advanced-stage intrahepatic cholangiocarcinoma (biliary tract cancer)"],"prefix":"10.1371","volume":"20","author":[{"given":"Teerachat","family":"Saeheng","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nisit","family":"Tongsiri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6389-0897","authenticated-orcid":true,"given":"Kesara","family":"Na-Bangchang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2025,4,28]]},"reference":[{"issue":"9","key":"pone.0321618.ref001","doi-asserted-by":"crossref","first-page":"2429","DOI":"10.1007\/s11136-021-02810-8","article-title":"Health-related quality of life in primary hepatic cancer: a systematic review assessing the methodological properties of instruments and a meta-analysis comparing treatment strategies","volume":"30","author":"K Wohlleber","year":"2021","journal-title":"Qual Life Res"},{"issue":"10064","key":"pone.0321618.ref002","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/S0140-6736(16)32453-9","article-title":"Regorafenib for patients with hepatocellular carcinoma who progressed on sorafenib treatment (RESORCE): a randomised, double-blind, placebo-controlled, phase 3 trial","volume":"389","author":"J Bruix","year":"2017","journal-title":"Lancet"},{"issue":"2","key":"pone.0321618.ref003","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1007\/s00520-012-1541-5","article-title":"Symptom clusters and symptom interference of HCC patients undergoing TACE: a cross-sectional study in China","volume":"21","author":"W Cao","year":"2013","journal-title":"Support Care Cancer"},{"issue":"7","key":"pone.0321618.ref004","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1038\/sj.bjc.6603325","article-title":"Somatostatin receptor expression, tumour response, and quality of life in patients with advanced hepatocellular carcinoma treated with long-acting octreotide","volume":"95","author":"J Cebon","year":"2006","journal-title":"Br J Cancer"},{"key":"pone.0321618.ref005","doi-asserted-by":"crossref","first-page":"e46","DOI":"10.1016\/j.ejca.2014.03.176","article-title":"P0132 A longitudinal prospective analysis of depression, anxiety, and quality of life in patients with hepatocellular carcinoma","volume":"50","author":"W-Y Chang-Chien","year":"2014","journal-title":"Eur J Cancer"},{"issue":"8","key":"pone.0321618.ref006","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1089\/acm.2016.0136","article-title":"Coriolus versicolor (Yunzhi) use as therapy in advanced hepatocellular carcinoma patients with poor liver function or who are unfit for standard therapy","volume":"23","author":"WY Chay","year":"2017","journal-title":"J Altern Complement Med"},{"issue":"1","key":"pone.0321618.ref007","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/S1470-2045(08)70285-7","article-title":"Efficacy and safety of sorafenib in patients in the Asia-Pacific region with advanced hepatocellular carcinoma: a phase III randomised, double-blind, placebo-controlled trial","volume":"10","author":"A-L Cheng","year":"2009","journal-title":"Lancet Oncol"},{"issue":"1","key":"pone.0321618.ref008","first-page":"65","article-title":"Health-related quality of life before and after surgical resection of hepatocellular carcinoma: a prospective study","volume":"19","author":"C-C Chiu","year":"2018","journal-title":"Asian Pac J Cancer Prev"},{"key":"pone.0321618.ref009","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1186\/1471-2407-10-457","article-title":"Thymostimulin versus placebo for palliative treatment of locally advanced or metastasised hepatocellular carcinoma: a phase III clinical trial","volume":"10","author":"MM Dollinger","year":"2010","journal-title":"BMC Cancer"},{"issue":"8","key":"pone.0321618.ref010","doi-asserted-by":"crossref","first-page":"1468","DOI":"10.1111\/liv.13711","article-title":"FACT-Hep increases the accuracy of survival prediction in HCC patients when added to ECOG performance status","volume":"38","author":"A Gm\u00fcr","year":"2018","journal-title":"Liver Int"},{"issue":"6","key":"pone.0321618.ref011","doi-asserted-by":"crossref","first-page":"1715","DOI":"10.1111\/liv.12750","article-title":"Pilot randomized trial of selective internal radiation therapy vs. chemoembolization in unresectable hepatocellular carcinoma","volume":"35","author":"FT Kolligs","year":"2015","journal-title":"Liver Int"},{"issue":"2","key":"pone.0321618.ref012","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1097\/MEG.0b013e32834dda64","article-title":"Comparison of survival and quality of life of hepatectomy and thrombectomy using total hepatic vascular exclusion and chemotherapy alone in patients with hepatocellular carcinoma and tumor thrombi in the inferior vena cava and hepatic vein","volume":"24","author":"J Liu","year":"2012","journal-title":"Eur J Gastroenterol Hepatol"},{"issue":"1","key":"pone.0321618.ref013","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1111\/j.1743-7563.2008.00142.x","article-title":"Assessment of health-related quality of life and patient benefit as outcome measures for clinical trials in hepatocellular carcinoma","volume":"4","author":"AK Nowak","year":"2008","journal-title":"Asia-Pac J Clncl Oncology"},{"issue":"21","key":"pone.0321618.ref014","doi-asserted-by":"crossref","first-page":"2689","DOI":"10.3748\/wjg.v18.i21.2689","article-title":"Health-related quality of life evaluated by tumor node metastasis staging system in patients with hepatocellular carcinoma","volume":"18","author":"C-X Qiao","year":"2012","journal-title":"World J Gastroenterol"},{"issue":"1","key":"pone.0321618.ref015","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1097\/NCC.0b013e3181b4367e","article-title":"Symptom clusters and quality of life in Korean patients with hepatocellular carcinoma","volume":"33","author":"E Ryu","year":"2010","journal-title":"Cancer Nurs"},{"issue":"10","key":"pone.0321618.ref016","doi-asserted-by":"crossref","first-page":"1358-1365.e1","DOI":"10.1016\/j.cgh.2013.04.028","article-title":"Increased quality of life among hepatocellular carcinoma patients treated with radioembolization, compared with chemoembolization","volume":"11","author":"R Salem","year":"2013","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"6","key":"pone.0321618.ref017","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1097\/NCC.0b013e31820d0c3f","article-title":"The influence of symptoms, social support, uncertainty, and coping on health-related quality of life among cholangiocarcinoma patients in northeast Thailand","volume":"34","author":"B Somjaivong","year":"2011","journal-title":"Cancer Nurs"},{"issue":"2","key":"pone.0321618.ref018","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1002\/pon.725","article-title":"Quality of life in patients diagnosed with primary hepatocellular carcinoma: hepatic arterial infusion of Cisplatin versus 90-Yttrium microspheres (Therasphere)","volume":"13","author":"J Steel","year":"2004","journal-title":"Psychooncology"},{"issue":"10","key":"pone.0321618.ref019","doi-asserted-by":"crossref","first-page":"2234","DOI":"10.1002\/cncr.21450","article-title":"Sexual functioning in patients with hepatocellular carcinoma","volume":"104","author":"J Steel","year":"2005","journal-title":"Cancer"},{"issue":"4","key":"pone.0321618.ref020","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1007\/s11136-004-3267-4","article-title":"Proxy ratings of health related quality of life in patients with hepatocellular carcinoma","volume":"14","author":"JL Steel","year":"2005","journal-title":"Qual Life Res"},{"issue":"2","key":"pone.0321618.ref021","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1007\/s11136-006-9111-2","article-title":"Health-related quality of life: hepatocellular carcinoma, chronic liver disease, and the general population","volume":"16","author":"JL Steel","year":"2007","journal-title":"Qual Life Res"},{"issue":"23","key":"pone.0321618.ref022","doi-asserted-by":"crossref","first-page":"3717","DOI":"10.1002\/cncr.28902","article-title":"Health-related quality of life as a prognostic factor in patients with advanced cancer","volume":"120","author":"JL Steel","year":"2014","journal-title":"Cancer"},{"issue":"1","key":"pone.0321618.ref023","doi-asserted-by":"crossref","first-page":"e23-30","DOI":"10.1016\/j.suronc.2011.10.005","article-title":"Health-related quality of life in patients with hepatocellular carcinoma after hepatic resection, transcatheter arterial chemoembolization, radiofrequency ablation or no treatment","volume":"21","author":"A Toro","year":"2012","journal-title":"Surg Oncol"},{"issue":"116","key":"pone.0321618.ref024","first-page":"1036","article-title":"Quality of life and the relevant factors in patients with chronic hepatitis B","volume":"59","author":"L Wang","year":"2012","journal-title":"Hepatogastroenterology"},{"issue":"6","key":"pone.0321618.ref025","doi-asserted-by":"crossref","first-page":"E46-51","DOI":"10.1097\/NCC.0000000000000233","article-title":"Factors affecting health-related quality of life in patients with cholangiocarcinoma in the northeastern region of Thailand","volume":"38","author":"S Woradet","year":"2015","journal-title":"Cancer Nurs"},{"issue":"27","key":"pone.0321618.ref026","doi-asserted-by":"crossref","first-page":"24550","DOI":"10.18632\/oncotarget.4076","article-title":"Sorafenib continuation or discontinuation in patients with unresectable hepatocellular carcinoma after a complete response","volume":"6","author":"Y Zhang","year":"2015","journal-title":"Oncotarget"},{"issue":"2","key":"pone.0321618.ref027","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1111\/jebm.12034","article-title":"Survival and health-related quality of life in patients with spinal metastases originated from primary hepatocellular carcinoma","volume":"6","author":"W Zheng","year":"2013","journal-title":"J Evid Based Med"},{"issue":"3","key":"pone.0321618.ref028","first-page":"285","article-title":"Survival and quality of life of cholangiocarcinoma patients: a prospective study over a 4 year period","volume":"19","author":"F Mihalache","year":"2010","journal-title":"J Gastrointestin Liver Dis"},{"issue":"5","key":"pone.0321618.ref029","doi-asserted-by":"crossref","first-page":"1355","DOI":"10.1016\/j.gastro.2003.07.015","article-title":"Successful photodynamic therapy for nonresectable cholangiocarcinoma: a randomized prospective study","volume":"125","author":"MEJ Ortner","year":"2003","journal-title":"Gastroenterology"},{"issue":"7","key":"pone.0321618.ref030","doi-asserted-by":"crossref","first-page":"1259","DOI":"10.1016\/j.ejca.2014.01.008","article-title":"Randomised phase II trial of photodynamic therapy plus oral fluoropyrimidine, S-1, versus photodynamic therapy alone for unresectable hilar cholangiocarcinoma","volume":"50","author":"DH Park","year":"2014","journal-title":"Eur J Cancer"},{"issue":"9","key":"pone.0321618.ref031","doi-asserted-by":"crossref","first-page":"e0163448","DOI":"10.1371\/journal.pone.0163448","article-title":"Health-related quality of life and survival of cholangiocarcinoma patients in northeastern region of Thailand","volume":"11","author":"S Woradet","year":"2016","journal-title":"PLoS One"},{"issue":"9","key":"pone.0321618.ref032","doi-asserted-by":"crossref","first-page":"1032","DOI":"10.1038\/bjc.2016.284","article-title":"Validation of the EORTC QLQ-BIL21 questionnaire for measuring quality of life in patients with cholangiocarcinoma and cancer of the gallbladder","volume":"115","author":"SD Kaupp-Roberts","year":"2016","journal-title":"Br J Cancer"},{"key":"pone.0321618.ref033","article-title":"Phase IIa clinical trial to evaluate safety and efficacy of capsule formulation of the standardized extract of Atractylodes Lancea (Thunb) DC in patients with advanced-stage intrahepatic cholangiocarcinoma","author":"K. Na-Bangchang","year":"2024","journal-title":"World J Chin Med"},{"issue":"2","key":"pone.0321618.ref034","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1093\/annonc\/mdj072","article-title":"Clinically meaningful changes in health-related quality of life in patients diagnosed with hepatobiliary carcinoma","volume":"17","author":"JL Steel","year":"2006","journal-title":"Ann Oncol"},{"issue":"2","key":"pone.0321618.ref035","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1037\/h0046016","article-title":"Convergent and discriminant validation by the multitrait-multimethod matrix","volume":"56","author":"DT CAMPBELL","year":"1959","journal-title":"Psychol Bull"},{"issue":"3 Suppl","key":"pone.0321618.ref036","first-page":"S178-89","article-title":"Effect sizes for interpreting changes in health status","volume":"27","author":"LE Kazis","year":"1989","journal-title":"Med Care"},{"issue":"5","key":"pone.0321618.ref037","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1007\/s11136-012-0217-4","article-title":"Validity of the FACT Hepatobiliary (FACT-Hep) questionnaire for assessing disease-related symptoms and health-related quality of life in patients with metastatic pancreatic cancer","volume":"22","author":"D Cella","year":"2013","journal-title":"Qual Life Res"},{"issue":"1","key":"pone.0321618.ref038","doi-asserted-by":"crossref","first-page":"401","DOI":"10.7314\/APJCP.2016.17.1.401","article-title":"Cholangiocarcinoma patient outcome in Northeastern Thailand: single-center prospective study","volume":"17","author":"V Luvira","year":"2016","journal-title":"Asian Pac J Cancer Prev"}],"container-title":["PLOS One"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0321618","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,28]],"date-time":"2025-04-28T17:33:55Z","timestamp":1745861635000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0321618"}},"subtitle":[],"editor":[{"given":"Ammal Mokhtar","family":"Metwally","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2025,4,28]]},"references-count":38,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2025,4,28]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0321618","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,4,28]]}}}